BridgeBio Oncology Therapeutics, Inc.
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 22 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | – | – | 0.01 | – | – | – | – | 0.00 | 2.32 | – | – | |
| – | – | – | – | -0.01 | – | – | – | – | 0.00 | -2.32 | – | – | |
| – | – | 0.56 | 0.96 | 0.76 | 1,067.53 | 50.73 | 546.60 | 0.81 | 0.48 | 497.33 | 614.90 | 2,025.55 | |
| – | – | 0.10 | 0.06 | 0.08 | 127.79 | 6.15 | 52.89 | 0.32 | 0.07 | 79.68 | 136.93 | 459.71 | |
| 0.00 | 0.00 | 0.66 | 1.02 | 0.84 | 1,195.31 | 56.89 | 599.49 | 1.13 | 0.54 | 574.68 | 751.83 | 2,482.94 | |
| 0.00 | 0.00 | -0.66 | -1.02 | -0.84 | -1,195.31 | -56.89 | -599.49 | -1.13 | -0.54 | -577.01 | -751.83 | -2,485.26 | |
| 0.00 | 0.00 | -0.66 | -0.93 | -0.74 | -1,075.56 | -54.23 | -566.46 | -1.03 | -0.49 | -526.11 | -705.20 | -2,274.89 | |
| 0.00 | 0.00 | -0.66 | -0.93 | -0.74 | -1,075.56 | -54.23 | -566.46 | -1.03 | -0.49 | -526.11 | -705.20 | -2,274.89 | |
| 0.00 | 0.00 | -0.65 | -1.01 | -0.83 | -1,192.47 | -56.75 | -595.88 | -1.13 | -0.54 | -574.68 | -705.20 | -2,431.62 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.